Author: Srivastava, Sukrit; Kamthania, Mohit; Singh, Soni; Saxena, Ajay K; Sharma, Nishi
Title: Structural basis of development of multi-epitope vaccine against Middle East respiratory syndrome using in silico approach Document date: 2018_11_21
ID: 33h22ikl_4
Snippet: For vaccine development, proteins critically involved in virus-host cell interaction, viral proliferation, and host cell disruption were chosen. Thirteen proteins of MERS-CoV proteome chosen for epitope screening included the following: S glycoprotein; E protein; N protein; M protein; ORFs (ORF3, ORF4a, ORF4b, and ORF5); ORF1a (4P16), a papain-like protease (PL(pro)); ORF1a (4RSP), a protease.....
Document: For vaccine development, proteins critically involved in virus-host cell interaction, viral proliferation, and host cell disruption were chosen. Thirteen proteins of MERS-CoV proteome chosen for epitope screening included the following: S glycoprotein; E protein; N protein; M protein; ORFs (ORF3, ORF4a, ORF4b, and ORF5); ORF1a (4P16), a papain-like protease (PL(pro)); ORF1a (4RSP), a protease
Search related documents:
Co phrase search for related documents- cell disruption and MERS cov: 1
- cell disruption and MERS cov proteome: 1
- cell disruption and vaccine development: 1
- cell disruption and viral proliferation: 1, 2
- cell disruption and virus host: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- cell disruption and virus host cell interaction: 1
- cell interaction and host cell disruption: 1, 2
- cell interaction and MERS cov: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- cell interaction and MERS cov proteome: 1
- cell interaction and vaccine development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- cell interaction and viral proliferation: 1
- cell interaction and virus host: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- cell interaction and virus host cell interaction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- epitope screening and MERS cov: 1
- epitope screening and vaccine development: 1, 2, 3, 4, 5
- epitope screening and virus host: 1
- host cell disruption and MERS cov: 1
- host cell disruption and MERS cov proteome: 1
- host cell disruption and vaccine development: 1
Co phrase search for related documents, hyperlinks ordered by date